Alan Catanzariti
Podiatrist · Pittsburgh, PANPI 1023098498
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $63,320 of the $79,508 with a category attached, or 79.6%. Arthrex accounts for 89.2% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $39,667, 3.4 times the $11,832 reported in 2019. Among podiatrist clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $519.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$71K
- Stryker$4K
- Mid-atlantic Surgical Systems, LLC$3K
- Exactech, Inc.$375
- Smith+Nephew$308
- Zimmer Biomet$247
- plus $516 from 7 others
What the payments were for
- Royalty or licence$3,5945%
- Speaking & faculty fees$63,32080%
- Travel & lodging$7,91710%
- Food & beverage$3,5024%
- Education$1,1751%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 103 | $70,908 |
| Stryker(2 entities) | 14 | $4,350 |
| Mid-atlantic Surgical Systems, LLC | 22 | $2,806 |
| Exactech, Inc. | 2 | $375 |
| Smith+Nephew | 3 | $308 |
| Zimmer Biomet | 2 | $247 |
| Medshape, Inc. | 1 | $137 |
| Polynovo North America LLC | 1 | $106 |
| Orthofix Medical, Inc. | 1 | $104 |
| Kerecis Limited | 1 | $99 |
| Amgen | 1 | $29 |
| Integra Lifesciences Corporation | 1 | $23 |
| Nextremity Solutions Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$79,508 in reported general payments places this provider in the 95th percentile of 445 podiatrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 76 | $517 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $204 |
| Gabapentin | 25 | $195 |
| Doxycycline Hyclate | 11 | $132 |
| Methylprednisolone | 27 | $130 |
| Meloxicam | 42 | $117 |
| Cefadroxil | 11 | $66 |
| Oxycodone Hcl | 26 | $57 |
| IbuIbuprofen | 14 | $39 |
| Cephalexin | 20 | $25 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Pittsburgh
- Beverly GruarinPittsburgh$20K
- Alexis SchuppPittsburgh$11K
- Jessica SciulliPittsburgh$6K
- Mark HofbauerBelle Vernon$1.1M
- Daniel PerezPhiladelphia$434K
- Christopher BarrettChester$229K
- John StarinskiPen Argyl$74K
- Kwasi KwaaduPhiladelphia$65K
- Luke CicchinelliPhiladelphia$62K
- James McGuirePhiladelphia$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.